Suri Anish 4
4 · Cue Biopharma, Inc. · Filed Aug 29, 2023
Insider Transaction Report
Form 4
Suri Anish
Chief Scientific Officer
Transactions
- Purchase
Common Stock
2023-08-25$2.76/sh+4,000$11,040→ 135,638 total
4 · Cue Biopharma, Inc. · Filed Aug 29, 2023
Common Stock